Monday, November 01, 2004

Ingen Technologies Embarks on National Marketing Venture With Southeastern Neuroscience Institute and Stanford Trading Center-Revenue from Venture Estimated at $45 million Over Next Two Years


For Release: 

Calimesa, CA – November 1, 2004 @ 9:15am EST - Ingen Technologies, Inc. (OTC: CRTZ) announced today it has signed a marketing contract with Stanford Trading Center, Inc. to market Secure Balance™ and patented wireless gas alarm products for Ingen Technologies.

Bob Dean Stanford, President of Stanford Trading Center, said, “We are pleased to have finalized a marketing program that will result in both of our companies joining forces to develop extensive sales in the medical industry throughout the country.”

Stanford Trading Company and the Southeastern Neuroscience Institute have agreed to work together in marketing the Company’s Secure Balance™ program. Jacob Green, M.D., a leading Neurologist and President of the Southeastern Neuroscience Institute said, “After consultation with Mr. Stanford and based on past performance, I estimate that we [Stanford Trading Center and the Southeastern Neuroscience Institute] can sell 5% of the neurology marketplace (14,000 physicians) or 700 units within 2 years and we can also sell about 200 or more hospitals. With 4,500 hospitals nationwide, that’s an estimated 5% market penetration in the first two years. We will advertise mainly to their outpatient facilities which will benefit the most from these products.”

Ingen Technologies sells the Secure Balance™ products and services for $53,000 per unit, and estimates revenue from Secure Balance to total more than $45M over the next two years.  

The successful Secure Balance™ program is an equipment, training and educational support system available to physicians throughout the United States. Over the past twelve months, and during the initial introduction of the Secure Balance™, the Company generated approximately $1 million in revenues and it is now being aggressively marketed throughout the U.S. More recently, the company’s sales have increased in proportion to the expansion of the Company’s marketing network. Ingen’s marketing strength is based on its superior products and an experienced professional team.

The Secure Balance™ program offers the most sophisticated clinical products for vestibular function testing and balance therapy compared to any of their competitors. “We offer the most medically accepted, comprehensive product line for vestibular function testing at prices lower, than our competitors,” said Scott Sand, CEO of Ingen Technologies.

More than two million people visit their doctor each year complaining of dizziness or vertigo and the Secure Balance ™ program can substantially help patients and decrease the number of fall related injuries. The elderly population is expected to double over the next decade and comprise the majority of balance disorder patients.

About Stanford Trading Company, Inc.

The Stanford Trading Center has provided small business resources and medical marketing programs for the past 25 years. Their primary function is marketing Secure Balance™, with focus on Internet and direct mail advertising. The Stanford Trading Center is associated with Department of Commerce, the Small Business Association and governments worldwide. They have facilities for TV Broadcasting and quality post production. For more information, visit: and


About Southeastern Neuroscience Institute, P.A.

The Southeastern Neuroscience Institute is a prestigious center of specialized medicine located in Jacksonville, Florida. The Company specializes in neuroscience medicine and provides clinical educational services to physicians worldwide through its Preferred Provider Care program. The Southeastern Neuroscience Institute is recognized by the American Academy of Neurology and American Academy of Balance Medicine. For more information, visit:


About Ingen Technologies

Ingen Technologies is a growth-oriented technology company that offers a diverse and progressive service and product line. The Company’s flagship product is its BAFI ™, the world’s first, wireless digital low gas warning system for pressurized gas cylinders. BAFI, now in its second generation, is an accurate and cost-effective, real-time pressurized gas warning system that will alert users when gas levels are approaching empty.

The BAFI line has multiple applications in the medical sector, safety and protection (fire and police), aircraft, recreation vehicle and outdoor uses, as well as home and residential, construction and military. BAFI is a patented product that meets or exceeds regulatory compliance of this time of product and is completed and in production.

For more information, visit:  and

Investor Relations Contact: Scott R. Sand, C.E.O & Chairman

                                                            Ingen Technologies, Inc.

                                                            285 E. County Line Road

                                                            Calimesa, CA 92320



                                                            800-777-1186 FAX

                                                            [email protected]

                                                            Rick McCaffrey, Investor Relations

                                                            OTC Financial Network

                                                            781-444-6100 x625

                                                            781-444-6101 FAX

                                                            [email protected]

Safe Harbor for Forward-Looking Statements:  This news release includes forward-looking statements that are made pursuant to “Safe Harbor” provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.

Download this article in PDF format: CRTZstanford110104d3.pdf

Thank you for visiting